GATE2BRAIN
A Healthtech startup included in the Barcelona & Catalonia Startup Hub
GATE2BRAIN
Gate2Brain develops a peptide-based drug delivery platform that enables the non-invasive transport of therapeutics across the blood-brain barrier. Its first product, G2B-002, is a novel therapy for pediatric brain tumors with intact BBB, such as DIPG and pGBM. The company also partners with pharma to apply its technology to other CNS diseases.
Industries & Technologies
Financial data
Other information
Funding
0.1M € (November 2020)
Minority stake unknown %
Investors: n.a.
0.5M € (July 2020)
Minority stake unknown %
Investors: Fundacion Botin
Source: Press releases newsletters & platforms company websites annual reports & accounts regulatory body sites & stock exchanges
Other startups near startup GATE2BRAIN
similar companies
Collaborators of Barcelona & Catalonia Startup Hub.
We teamed up with business associations, universities and startup incubators to create the Barcelona & Catalonia Startup Hub.